04171nam 2200733 a 450 991082472390332120200520144314.09786611237189978128123718712812371839780470170113047017011597804701701060470170107(CKB)1000000000407914(EBL)333734(OCoLC)476138229(SSID)ssj0000117350(PQKBManifestationID)11128208(PQKBTitleCode)TC0000117350(PQKBWorkID)10048946(PQKB)10416506(MiAaPQ)EBC333734(Au-PeEL)EBL333734(CaPaEBR)ebr10226803(CaONFJC)MIL123718(PPN)199222746(OCoLC)84152893(FINmELB)ELB178942(Perlego)2753843(EXLCZ)99100000000040791420070209d2008 uy 0engur|n|---|||||txtccrCancer vaccines and tumor immunity /[edited by] Rimas Orentas, James W. Hodge, Bryon D. Johnson1st ed.Hoboken, N.J. Wiley-Intersciencec20081 online resource (352 p.)Description based upon print version of record.9780470074749 0470074744 Includes bibliographical references and index.CANCER VACCINES AND TUMOR IMMUNITY; CONTENTS; Contributors; Foreword CANCER VACCINES AND CANCER IMMUNOTHERAPY: A NEW PARADIGM; I INTRODUCTION; 1 CANCER VACCINES: PROGRESS AND PROMISE; II ADJUVANT THERAPY: ENHANCING THE ENDOGENOUS IMMUNE RESPONSE; 2 FULLY SYNTHETIC CARBOYHYDRATE-BASED ANTITUMOR VACCINES; 3 BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY OF GENITOURINARY CANCER; 4 STIMULATION OF TOLL-LIKE RECEPTOR 9 FOR ENHANCING VACCINATION; III ANTIGEN-SPECIFIC THERAPY: NOVEL PRESENTATION OF PEPTIDE AND PROTEIN ANTIGENS; 5 POLYEPITOPE VACCINES6 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPY: HPV-ASSOCIATED CERVICAL CANCER AS A MODEL SYSTEM7 POXVIRAL VECTORS FOR CANCER VACCINES: STATE OF THE ART; 8 IMMUNOTHERAPEUTIC STRATEGIES AGAINST CANCER USING Listeria monocytogenes AS A VECTOR FOR TUMOR ANTIGENS; 9 COUPLING INNATE AND ADAPTIVE IMMUNITY WITH YEAST-BASED CANCER IMMUNOTHERAPY; IV CELL-BASED THERAPY: USING CANCER CELLS AS A MEANS TO INDUCE SPECIFIC TUMOR IMMUNITY; 10 ALLOGENEIC WHOLE-CELL VACCINES; 11 JUMP-STARTING TUMOR IMMUNITY WITH BREAST CANCER THERAPEUTICS; 12 T-REGULATORY CELL MANIPULATION IN TUMOR IMMUNOTHERAPY13 TUMOR VACCINATION AFTER AUTOLOGOUS HSCT: WHAT HAS BEEN LEARNED FROM EXPERIMENTAL MODELS14 VACCINES IN THE SETTING OF HEMATOPOIETIC STEM CELL TRANSPLANTATION; 15 INTRATUMOR GENERATION OF VIGOROUS ANTITUMOR IMMUNE RESPONSES; 16 CANCER IMMUNOTHERAPY: UNTAPPING THE POTENTIAL OF COSTIMULATORY MOLECULES BEYOND CTLA-4; V DEFINING EFFECTIVE CLINICAL RESPONSES; 17 ADVANCES IN IMMUNE MONITORING STRATEGIES FOR CANCER VACCINES AND IMMUNOTHERAPY; 18 IMMUNE EVALUATION OF CANCER VACCINES; IndexCancer Vaccines and Tumor Immunity offers a review of the basic scientific discoveries that have moved forward into clinical trials. Presented in the context of real-world human research and experimentation, these major scientific advances demonstrate how our understanding of immune activation, T-regulatory cells, and autoimmunity will impact cancer vaccine design. The authors also explain how vaccination in the context of bone marrow transplantation will open new avenues for clinical study in the future.Cancer vaccinesTumorsImmunological aspectsCancer vaccines.TumorsImmunological aspects.616.99/407Orentas Rimas1648337Hodge James W1648338Johnson Bryon D1648339MiAaPQMiAaPQMiAaPQBOOK9910824723903321Cancer vaccines and tumor immunity3996402UNINA